SG11202004442VA - Oxoacridinyl acetic acid derivatives and methods of use - Google Patents

Oxoacridinyl acetic acid derivatives and methods of use

Info

Publication number
SG11202004442VA
SG11202004442VA SG11202004442VA SG11202004442VA SG11202004442VA SG 11202004442V A SG11202004442V A SG 11202004442VA SG 11202004442V A SG11202004442V A SG 11202004442VA SG 11202004442V A SG11202004442V A SG 11202004442VA SG 11202004442V A SG11202004442V A SG 11202004442VA
Authority
SG
Singapore
Prior art keywords
oxoacridinyl
methods
acetic acid
acid derivatives
derivatives
Prior art date
Application number
SG11202004442VA
Other languages
English (en)
Inventor
Brian T Chamberlain
James M Rice
Finith E Jernigan
Woody Sherman
Meghana M Kulkarni
Sharon Shechter
Bryce K Allen
Dazhi Tan
Kristen A Marino
Zhixiong Lin
Original Assignee
Silicon Swat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silicon Swat Inc filed Critical Silicon Swat Inc
Publication of SG11202004442VA publication Critical patent/SG11202004442VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
SG11202004442VA 2017-11-20 2018-11-20 Oxoacridinyl acetic acid derivatives and methods of use SG11202004442VA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762588820P 2017-11-20 2017-11-20
US201862631530P 2018-02-16 2018-02-16
US201862723660P 2018-08-28 2018-08-28
PCT/US2018/062021 WO2019100061A1 (en) 2017-11-20 2018-11-20 Oxoacridinyl acetic acid derivatives and methods of use

Publications (1)

Publication Number Publication Date
SG11202004442VA true SG11202004442VA (en) 2020-06-29

Family

ID=66540425

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004442VA SG11202004442VA (en) 2017-11-20 2018-11-20 Oxoacridinyl acetic acid derivatives and methods of use

Country Status (13)

Country Link
US (2) US10745358B2 (zh)
EP (1) EP3713920A4 (zh)
JP (1) JP7323539B2 (zh)
KR (1) KR20200100081A (zh)
CN (1) CN111630036A (zh)
AU (1) AU2018368789B2 (zh)
BR (1) BR112020009592A2 (zh)
CA (1) CA3079262A1 (zh)
IL (1) IL274796A (zh)
MX (1) MX2020004902A (zh)
PH (1) PH12020550652A1 (zh)
SG (1) SG11202004442VA (zh)
WO (1) WO2019100061A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3675859A4 (en) 2017-08-31 2021-06-30 Sperovie Biosciences, Inc. COMPOUNDS, COMPOSITIONS AND PROCEDURES FOR TREATMENT OF DISEASES
CN114302875A (zh) * 2019-05-16 2022-04-08 斯汀塞拉股份有限公司 氧代吖啶基乙酸衍生物及使用方法
KR20220024467A (ko) * 2019-06-12 2022-03-03 리부 세라퓨틱스 에스.에이. 인터페론 유전자 자극인자(sting)의 차세대 조절제
CN112442033A (zh) * 2019-08-28 2021-03-05 迈德欣国际有限公司 Sting通路调节剂及其用途
CN112624972A (zh) * 2019-09-24 2021-04-09 中国人民解放军军事科学院军事医学研究院 吖啶酮类化合物及医药用途
CN116813647A (zh) * 2019-11-02 2023-09-29 上海凌达生物医药有限公司 一类含氮稠环类sting调节剂类化合物、制备方法和用途
CN111039849B (zh) * 2019-12-26 2021-07-06 阜阳欣奕华材料科技有限公司 一种含有咔唑环类化合物的制备方法
TW202200136A (zh) 2020-04-10 2022-01-01 日商小野藥品工業股份有限公司 癌治療方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681360A (en) 1971-04-09 1972-08-01 Hoffmann La Roche Antiviral substituted acridanones
JPH0867873A (ja) 1994-08-29 1996-03-12 Pioneer Electron Corp 有機エレクトロルミネッセンス素子
CA2213706A1 (en) 1995-03-02 1996-09-06 Yamanouchi Pharmaceutical Co., Ltd. Novel quinuclidine derivative having tricyclic hetereo condensed ring
EP0857721A4 (en) 1995-10-04 1999-07-28 Eisai Co Ltd ACRIDONE-BASED COMPOUNDS
US6333322B1 (en) * 1996-03-13 2001-12-25 Eisai Co., Ltd. Nitrogen-containing tricyclic compounds and drugs containing the same
RU2118532C1 (ru) * 1996-04-10 1998-09-10 Олег Викторович Травкин Противоинфекционное, противовоспалительное и противоопухолевое лекарственное средство
JPH11100373A (ja) * 1997-09-26 1999-04-13 Eisai Co Ltd 新規フェノチアジン誘導体及びその医薬
RU2197248C2 (ru) * 2001-03-20 2003-01-27 Травкин Олег Викторович Лекарственный препарат, обладающий иммуномоделирующим, иммунокоррегирующим, противопаразитарным, противосклеротическим, противовирусным, противобактериальным, противогрибковым, противовоспалительным и противоопухолевым действием, и способ его приготовления
GB0113435D0 (en) 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Acridone derivatives as labels for fluorescence detection of target materials
GB0113434D0 (en) 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Quinacridone derivatives as labels for fluorescence detection of biological materials
EP1627224A1 (en) 2003-05-28 2006-02-22 Amersham Biosciences UK Limited Differential analysis of cell surface proteins on closed membrane structures by labelling with dyes in the presence of an internal standard
EP1735059A2 (en) * 2004-04-06 2006-12-27 The Procter and Gamble Company Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
JP2006004736A (ja) 2004-06-17 2006-01-05 Sumitomo Chemical Co Ltd 光電変換素子及び光電変換素子用色素
WO2008021745A2 (en) 2006-08-16 2008-02-21 Itherx Pharmaceuticals, Inc. Hepatitis c virus entry inhibitors
JP2008090130A (ja) * 2006-10-04 2008-04-17 Konica Minolta Medical & Graphic Inc 感光性平版印刷版材料
US20110039289A1 (en) 2008-03-14 2011-02-17 Pierre Graves Fluorogenic peptides and their method of production
JP2009271403A (ja) 2008-05-09 2009-11-19 Konica Minolta Medical & Graphic Inc 感光性平版印刷版材料および平版印刷版の製造方法
JP5717959B2 (ja) 2009-11-17 2015-05-13 株式会社Adeka 芳香族スルホニウム塩化合物
US8618125B2 (en) 2011-01-14 2013-12-31 Heptiva LLC Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
WO2013022740A2 (en) 2011-08-05 2013-02-14 Corning Incorporated Gpr35 ligands and the uses thereof
JP6082474B2 (ja) 2013-09-30 2017-02-15 富士フイルム株式会社 感光性樹脂組成物、硬化膜の製造方法、硬化膜、有機ｅｌ表示装置および液晶表示装置
AU2014340269B2 (en) 2013-10-21 2018-06-21 Drexel University Use of STING agonists to treat chronic hepatitis B virus infection
CN103709122B (zh) 2013-11-29 2016-05-25 四川大学 用于治疗的抗肿瘤和抗真菌化合物
WO2016179702A1 (en) * 2015-05-11 2016-11-17 Ranju Ralhan Acridinone compositions for treating head and neck cancers and methods of prognosing head and neck cancers
US11938128B2 (en) 2017-03-10 2024-03-26 Albert Einstein College Of Medicine Small molecule BAX inhibitors and uses thereof

Also Published As

Publication number Publication date
EP3713920A1 (en) 2020-09-30
CA3079262A1 (en) 2019-05-23
US20230113570A1 (en) 2023-04-13
KR20200100081A (ko) 2020-08-25
CN111630036A (zh) 2020-09-04
AU2018368789A1 (en) 2020-06-11
PH12020550652A1 (en) 2021-04-26
WO2019100061A1 (en) 2019-05-23
JP7323539B2 (ja) 2023-08-08
MX2020004902A (es) 2020-09-09
US10745358B2 (en) 2020-08-18
US20190161449A1 (en) 2019-05-30
AU2018368789B2 (en) 2022-06-02
IL274796A (en) 2020-07-30
BR112020009592A2 (pt) 2020-11-03
EP3713920A4 (en) 2021-04-14
JP2021503501A (ja) 2021-02-12

Similar Documents

Publication Publication Date Title
IL304455A (en) Methods and intermediates for the preparation of bile acid derivatives
HK1252688A1 (zh) 製備膽汁酸及其衍生物的方法
IL274796A (en) Oxoacridinyl acetic acid derivatives and methods of use
EP3288958A4 (en) Compositions of obeticholic acid and methods of use
EP3179907A4 (en) Ecg patch and methods of use
EP3193746A4 (en) Expandable body device and method of use
EP3245291A4 (en) Novel micro-dystrophins and related methods of use
EP3615515A4 (en) PROPIONIC ACID DERIVATIVES AND RELATED METHODS OF USE
HK1254055A1 (zh) 製備奧貝膽酸及其衍生物的方法
EP3551033A4 (en) ENDOSCOPE AND METHOD OF USE
IL256971A (en) Methods for preparation of bile acids and derivatives thereof
EP3169251A4 (en) Pulmonary artery implant apparatus and methods of use thereof
IL250270A0 (en) Abiraterone acetate formulations and methods of use
EP3615514A4 (en) PROPIONIC ACID DERIVATIVES AND METHOD OF USING THEREOF
EP3265476A4 (en) Protoxin-ii variants and methods of use
IL257223A (en) New crystalline form and acetic acid adducts of palbociclib
EP3109230A4 (en) Class of carboxylic acid derivatives and use thereof in preparation of prodrugs
EP3277304A4 (en) Protoxin-ii variants and methods of use
HK1246279A1 (zh) C14-位羥基酯化的雷公藤甲素氨基酸衍生物、及其製備方法和應用
EP3448375C0 (en) BENZOYLGLYCINE DERIVATIVES AND METHODS OF PRODUCING AND USING SUCH DERIVATIVES
SG11201605915WA (en) Furo-3-carboxamide derivatives and methods of use
IL262405A (en) Methods for the preparation of obeticholic acid and derivatives thereof
HK1248227A1 (zh) 酚噻嗪化合物及其用途
HK1232209A1 (zh) 製備 -乙酰氧基丙酸及其衍生物的方法
EP3324959A4 (en) LICOFELONE DERIVATIVES AND METHOD OF USE